Edward Markey (D-MA)

Modernizing Opioid Treatment Access Act 2.0 of 2026

S. 4941 · Senate bill Health

A Democratic bill with 1 Republican cosponsor · See all 8 cosponsors

Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Modernizing Opioid Treatment Access Act 2.0 of 2026 aims to expand access to methadone for treating opioid use disorder. It allows certain qualified practitioners to prescribe methadone to be dispensed through pharmacies for supervised or unsupervised use. These practitioners include specific addiction medicine specialists or those determined qualified by the Secretary. The bill mandates that prescribing occurs exclusively via electronic means for liquid or dispersible tablet formulations. Additionally, treatment may be provided through telemedicine. The Act also establishes oversight through required reports to Congress from the DEA.

Yes· 3 of 4

  • Scored +8

    Does this do more about addiction and overdose deaths?

    The bill directly targets the opioid crisis by diversifying treatment access methods.

  • Scored +7

    Does this make health care easier to get in general?

    The bill expands access to methadone treatment through pharmacies and telemedicine.

  • Scored +5

    Does this make what the government does easier for the public to see?

    The bill mandates annual reports to Congress regarding methadone prescribing and registration statistics.

The opposite

  • Scored -2

    Does this protect people from being watched or searched?

    The bill notes potential differences in confidentiality protections when using pharmacies for dispensing.